Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis

Critical Care Medicine

Volumn 21, Issue 3, 1993, Pages 318-327

  Fisher Jr , C J ^a   Opal, S M ^a   Dhainaut, J F ^a   Stephens, S ^a   Zimmerman, J L ^a   Nightingale, P ^a   Harris, S J ^a   Schein, R M H ^a   Panacek, E A ^a   Vincent , J L ^a   Foulke, G E ^a   Warren, E L ^a   Garrard, C ^a   Park, G ^a   Bodmer, M W ^a   Cohen, J ^a   Van der Linden, C ^a   Cross, A S ^a   Sadoff, J C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

anti cytokine; critical illness; immunotherapy; infection; interleukin 1; interleukin 6; monoclonal antibody; sepsis; shock, septic; tumor necrosis factor

Indexed keywords

CB 0006; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK;

EID: 0027406403     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199303000-00006     Document Type: Article

References (0)